Gynaecologic and breast cancers in women living with HIV in South Africa: A record linkage study
International Journal of Cancer · 2024
DOI: 10.1002/ijc.34712 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, 2024. Verfasst von Tafadzwa G Dhokotera und 6 weiteren Autor:innen. Beteiligte Einrichtung: Swiss Tropical and Public Health Institute, Allschwil, Switzerland. Hauptthemen laut MEDLINE: HIV Infections, Papillomavirus Infections, Breast Neoplasms, Uterine Cervical Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, CRDF Global.
Abstract (Originalsprache)
Breast and gynaecologic cancers account for approximately half of all cancers diagnosed amongst women in South Africa, many of whom also live with HIV. We aimed to determine the incidence of and risk factors for developing breast and gynaecologic cancers in women living with HIV (WLHIV) in South Africa. This is a longitudinal analysis of the South African HIV Cancer Match study including women aged ≥15 years with two or more HIV‐related laboratory tests. We used Cox proportional hazard models to determine the association of Human Papilloma Virus (HPV)‐related and hormone‐related gynaecologic cancer with patient‐ and municipal‐level characteristics. From 3 447 908 women and 10.5 million years of follow‐up, we identified 11 384 incident and 7612 prevalent gynaecologic and breast cancers. The overall crude incidence rate was 108/1 00 000 person‐years (pyears) (95% confidence interval [CI]: 106‐110), with the highest incidence observed for cervical cancer (70/1 00 000 pyears; 95% CI: 68.5‐71.7). Low CD4 cell counts and high HIV RNA viral loads increased the risk of cervical and other HPV‐related cancers. Age was associated with both HPV‐related and hormone‐related cancers. Women accessing health facilities in high socioeconomic position (SEP) municipalities were more likely to be diagnosed with HPV‐related cancers and breast cancer than women accessing care in low SEP municipalities. It is important to improve the immunologic status of WLHIV as part of cancer prevention strategies in WLHIV. Cancer prevention and early detection programmes should be tailored to the needs of women ageing with HIV. In addition, SEP disparities in cancer diagnostic services have to be addressed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Swiss Tropical and Public Health Institute, Allschwil, Switzerland.
- University of Basel, Basel, Switzerland.
- Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.
- National Cancer Registry, National Health Laboratory Service, Johannesburg, South Africa.
- School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.
- South African DSI NRF Centre of Excellence in Epidemiological Modelling and Analysis, Stellenbosch University, Stellenbosch, South Africa.
ORCID-Profile: Tafadzwa G Dhokotera, Mazvita Muchengeti, Eliane Rohner
Förderung
- NIAID NIH HHS
- NIH HHS
- CRDF Global
- National Institutes of Health
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Zitieren
APA
Dhokotera, T. G., Muchengeti, M., Davidović, M., Rohner, E., Olago, V., Egger, M., & Bohlius, J. (2024). Gynaecologic and breast cancers in women living with HIV in South Africa: A record linkage study. International Journal of Cancer. https://doi.org/10.1002/ijc.34712
Vancouver
Dhokotera TG, Muchengeti M, Davidović M, Rohner E, Olago V, Egger M, et al. Gynaecologic and breast cancers in women living with HIV in South Africa: A record linkage study. International Journal of Cancer. 2024. doi:10.1002/ijc.34712
BibTeX
@article{Dhokotera2024,
author = {Dhokotera, Tafadzwa G and Muchengeti, Mazvita and Davidović, Maša and Rohner, Eliane and Olago, Victor and Egger, Matthias and Bohlius, Julia},
title = {Gynaecologic and breast cancers in women living with HIV in South Africa: A record linkage study},
journal = {International Journal of Cancer},
year = {2024},
doi = {10.1002/ijc.34712}
}
EUVIMED